Clinical Trials

NCT IdNCT04833855
TitleStudy to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria
ConditionChronic Spontaneous Urticaria
StudyTypeInterventional
OrganizationAmgen
Sponsor/CollaboratorsAmgen
StatusNot yet recruiting
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
DescriptionThe primary objective of this study is to evaluate the effect of tezepelumab on improvement in the Urticaria Activity Score over 7 days (UAS7).